Literature DB >> 2168419

Hepatic 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase. Use of site-directed mutagenesis to evaluate the roles of His-258 and His-392 in catalysis.

A Tauler1, K Lin, S J Pilkis.   

Abstract

The current model for hepatic 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase divides the protein into two functional domains: an N-terminal kinase domain and a carboxyl-terminal bisphosphatase domain. Site-directed mutagenesis was used to evaluate the role of two putative bisphosphatase active site histidyl residues in catalysis. His-258 has been implicated as a phosphoacceptor (Pilkis, S. J., Lively, M. O., and El-Maghrabi, M. R. (1987) J. Biol. Chem. 262, 12672-12675), and the importance of this residue was confirmed when it was mutated to alanine and neither bisphosphatase activity nor a phosphoenzyme intermediate could be detected. Mutation of His-392 to alanine produced an enzyme which had five percent of wild-type fructose 2,6-bisphosphatase activity, and the rate of phosphoenzyme formations was decreased from 4800 nmol/min/mg to 2.9 nmol/min/mg. Mutation of His-392 to phenylalanine, lysine, or aspartic acid also produced proteins that did not hydrolyze fructose 2,6-bisphosphate or form a phosphoenzyme intermediate. These results are consistent with an important role for His-392 in the bisphosphatase reaction, probably as a proton donor, and with its designation as an active site residue based on homology modeling (Bazan (1989) Proc. Natl. Acad. Sci. U.S.A. 86, 9642-9646). H258A had the same Vmax for 6-phosphofructo-2-kinase as the wild-type enzyme, and the mutant's kinase was inhibited by cAMP-dependent phosphorylation. In addition, H392F and H392K did not catalyze the kinase reaction, although H392D had normal kinase activity which was also modulated by cAMP-dependent phosphorylation in the same manner as the wild-type enzyme. Thus, an active bisphosphatase domain is not a necessary condition for phosphorylation-induced changes in 6-phosphofructo-2-kinase activity. The results also suggest that structural and/or active site interactions exist between the two domains of the enzyme.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2168419

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  Involvement of the chicken liver 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase sequence His444-Arg-Glu-Arg in modulation of the bisphosphatase activity by its kinase domain.

Authors:  Z Zhu; S Ling; Q H Yang; L Li
Journal:  Biochem J       Date:  2001-07-15       Impact factor: 3.857

2.  Separate bisphosphatase domain of chicken liver 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase: the role of the C-terminal tail in modulating enzyme activity.

Authors:  L Li; S Ling; C l Wu; W Yao; G Xu
Journal:  Biochem J       Date:  1997-12-15       Impact factor: 3.857

3.  Mutagenesis of charged residues in a conserved sequence in the 2-kinase domain of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase.

Authors:  L Bertrand; D Vertommen; E Feytmans; A Di Pietro; M H Rider; L Hue
Journal:  Biochem J       Date:  1997-02-01       Impact factor: 3.857

4.  Substrate binding and activation in the active site of cytochrome c nitrite reductase: a density functional study.

Authors:  Dmytro Bykov; Frank Neese
Journal:  J Biol Inorg Chem       Date:  2010-12-02       Impact factor: 3.358

5.  Type 2 Diabetes Dysregulates Glucose Metabolism in Cardiac Progenitor Cells.

Authors:  Joshua K Salabei; Pawel K Lorkiewicz; Parul Mehra; Andrew A Gibb; Petra Haberzettl; Kyung U Hong; Xiaoli Wei; Xiang Zhang; Qianhong Li; Marcin Wysoczynski; Roberto Bolli; Aruni Bhatnagar; Bradford G Hill
Journal:  J Biol Chem       Date:  2016-05-05       Impact factor: 5.157

6.  Overexpression of 6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase in mouse liver lowers blood glucose by suppressing hepatic glucose production.

Authors:  C Wu; D A Okar; C B Newgard; A J Lange
Journal:  J Clin Invest       Date:  2001-01       Impact factor: 14.808

Review 7.  Covalent control of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase: insights into autoregulation of a bifunctional enzyme.

Authors:  I J Kurland; S J Pilkis
Journal:  Protein Sci       Date:  1995-06       Impact factor: 6.725

8.  Identification of transient intermediates in the bisphosphatase reaction of rat liver 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase by 31P-NMR spectroscopy.

Authors:  D A Okar; L T Kakalis; S S Narula; I M Armitage; S J Pilkis
Journal:  Biochem J       Date:  1995-05-15       Impact factor: 3.857

9.  Site-directed mutagenesis of rat muscle 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase: role of Asp-130 in the 2-kinase domain.

Authors:  M H Rider; K M Crepin; M De Cloedt; L Bertrand; L Hue
Journal:  Biochem J       Date:  1994-05-15       Impact factor: 3.857

10.  Study of the roles of Arg-104 and Arg-225 in the 2-kinase domain of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase by site-directed mutagenesis.

Authors:  M H Rider; K M Crepin; M De Cloedt; L Bertrand; D Vertommen; L Hue
Journal:  Biochem J       Date:  1995-07-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.